Q32 Bio Inc (QTTB) — Strategic Asset Allocation Index

Latest as of December 2025: 0.0%

Q32 Bio Inc (QTTB) has a Strategic Asset Allocation Index of 0.0% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $42.01 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Q32 Bio Inc's balance sheet to measure how much of total assets are equity-financed.

SAAI

0.0%
Strategic Assets / Net Assets

Strategic Assets

$0.00
PP&E + LT Investments

PP&E

$-
USD

Net Assets

$42.01 Million
USD

Q32 Bio Inc Strategic Asset Allocation Index (2024–2025)

This chart shows how Q32 Bio Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $42.01 Million USD. For live market cap and overall valuation, see Q32 Bio Inc market capitalisation.

Annual Strategic Asset Allocation Index for Q32 Bio Inc (2024–2025)

The table below presents the year-by-year Strategic Asset Allocation Index for Q32 Bio Inc from 2024 to 2025, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Q32 Bio Inc (QTTB) shareholders funds for net asset value and shareholders' equity analysis.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2025 0.0% $0.00 $- $0.00 $42.01 Million ▼ -45.8 pp
2024 45.8% $2.60 Million $- $2.60 Million $5.67 Million
pp = percentage points